FDA approves GLP-1 weight loss pill Foundayo from Eli Lilly
The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe…
FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1…
Kerry pharmacist welcomes medicine blister packs agreement
A Kerry pharmacist has welcomed the agreement reached on medicine blister packs. The HSE and the Irish Pharmacy…
Digant Sharma and Vibha Jain Launch Hypnotherapy Private Limited
SMPL Mumbai (Maharashtra) [India], April 1: In a significant development for India’s mental wellness and holistic healing landscape,…
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
– PGN-EDODM1 was generally well-tolerated with all adverse events mild or moderate and no serious adverse events reported…
The FDA is expected to lift restrictions on certain peptides, the NYT reports
Nike craters after issuing weak revenue guidance Sportswear kingpin Nike is tumbling on Wednesday morning after saying it…
New rules will make modern medications easier to access in Czechia
Patients in Czechia will soon find it easier to access modern treatments for chronic conditions as the Ministry…
Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details | India News
File photo: ANI NEW DELHI: The Centre has issued a detailed advisory on the use, risks and regulation…
‘Allocate key chemicals to avert drug shortages’, says Pharmexcil amid West Asia war
New Delhi: The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged the government to allocate raw materials…
NHS head warns UK ‘days away’ from running out of aspirin and paracetamol
The NHS lead has said that health bosses are “really worried” as pharmacies across the UK could be…